OB-005

N/A

Report date: 2025/01/09 14:49:28
NME

Base Information

Drug NameOB-005
Drug Alias NameOB-005
ClassificationOther
Mechanisms of ActionGlucose-Dependent Insulinotropic Polypeptide Receptor modulators
TargetsGlucose-Dependent Insulinotropic Polypeptide Receptor
Therapy Area/IndicationsObesityMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrion Biotechnology Canada Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsObesityMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A